R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L− CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors

Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of Virology 2006-01, Vol.80 (2), p.854-865
Hauptverfasser: GONDOIS-REY, Francoise, BIANCOTTO, Angelique, FERNANDEZ, Marcelo Antonio, BETTENDROFFER, Lise, BLAZKOVA, Jana, TREJBALOVA, Katerina, PION, Marjorie, HIRSCH, Ivan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 865
container_issue 2
container_start_page 854
container_title Journal of Virology
container_volume 80
creator GONDOIS-REY, Francoise
BIANCOTTO, Angelique
FERNANDEZ, Marcelo Antonio
BETTENDROFFER, Lise
BLAZKOVA, Jana
TREJBALOVA, Katerina
PION, Marjorie
HIRSCH, Ivan
description Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       
doi_str_mv 10.1128/JVI.80.2.854-865.2006
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1346836</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67594171</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-a5dc7137577a291f6f3c30c484139746efbb63aea8cac3fb4aa6385ff2ef1ef33</originalsourceid><addsrcrecordid>eNpVUUuOEzEUtBCIGQJHAHkDG9TBbn_a2SCNwmeCIhiNQsTOcpzniUfddrC7g3ID1lyDW3ESPEqUgZV_9arKVQg9p2RMaa3efFrOxoqM67ESvFJSjGtC5AN0TslEVUJQ_hCdE1LXlWDq2xl6kvMtIZRzyR-jMypZoyaqOUe_rwVemuRN6DOODl8OnQl41nVDiGtw3noIdo-XPg0ZL_ZbwBRfJXCQIPTetO0ez4ID2-PpO1nP__z8VTb8NV7gKbRtxias8UUCfBX708A1ZJ_7ooj7iD8PtoWY_RrK_Q5SBrxIJmSb_LY35TQLG7_yfUz5KXrkTJvh2XEdoa8f3i-ml9X8y8fZ9GJe2fK7vjJibRvKGtE0pp5QJx2zjFiuOGWThktwq5VkBoyyxjK34sZIpoRzNTgKjrERenvg3Q6rDta2GE-m1dvkO5P2Ohqv_38JfqNv4k5TxqVishC8OhKk-H2A3OvOZ1vyMAHikLVsxITT4nGExAFoU8y5xHoSoUTf1axLzVoRXetSsy4167uay9yLfx3eTx17LYCXR4DJ1rSuJGp9vsc1QhIlScHhA27jbzY_fAJtcqdvd_4kyv4C9kbAiA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67594171</pqid></control><display><type>article</type><title>R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L− CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>GONDOIS-REY, Francoise ; BIANCOTTO, Angelique ; FERNANDEZ, Marcelo Antonio ; BETTENDROFFER, Lise ; BLAZKOVA, Jana ; TREJBALOVA, Katerina ; PION, Marjorie ; HIRSCH, Ivan</creator><creatorcontrib>GONDOIS-REY, Francoise ; BIANCOTTO, Angelique ; FERNANDEZ, Marcelo Antonio ; BETTENDROFFER, Lise ; BLAZKOVA, Jana ; TREJBALOVA, Katerina ; PION, Marjorie ; HIRSCH, Ivan</creatorcontrib><description>Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       </description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.80.2.854-865.2006</identifier><identifier>PMID: 16378987</identifier><language>eng</language><publisher>Washington, DC: American Society for Microbiology</publisher><subject>Biological and medical sciences ; CD4-Positive T-Lymphocytes - immunology ; CD4-Positive T-Lymphocytes - virology ; Cells, Cultured ; Drug Resistance, Multiple, Viral ; Fundamental and applied biological sciences. Psychology ; HIV Infections - virology ; HIV-1 - drug effects ; HIV-1 - metabolism ; HIV-1 - physiology ; HLA-DR Antigens ; Human viral diseases ; Humans ; Infectious diseases ; L-Selectin - genetics ; Leukocytes, Mononuclear ; Lymphocyte Activation ; Medical sciences ; Microbiology ; Miscellaneous ; Palatine Tonsil ; Pathogenesis and Immunity ; Receptors, CCR5 - metabolism ; Receptors, CXCR4 - metabolism ; Reverse Transcriptase Inhibitors - pharmacology ; Species Specificity ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Virology ; Virus Replication - drug effects</subject><ispartof>Journal of Virology, 2006-01, Vol.80 (2), p.854-865</ispartof><rights>2006 INIST-CNRS</rights><rights>Copyright © 2006, American Society for Microbiology 2006</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-a5dc7137577a291f6f3c30c484139746efbb63aea8cac3fb4aa6385ff2ef1ef33</citedby><cites>FETCH-LOGICAL-c464t-a5dc7137577a291f6f3c30c484139746efbb63aea8cac3fb4aa6385ff2ef1ef33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1346836/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1346836/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17560860$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16378987$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>GONDOIS-REY, Francoise</creatorcontrib><creatorcontrib>BIANCOTTO, Angelique</creatorcontrib><creatorcontrib>FERNANDEZ, Marcelo Antonio</creatorcontrib><creatorcontrib>BETTENDROFFER, Lise</creatorcontrib><creatorcontrib>BLAZKOVA, Jana</creatorcontrib><creatorcontrib>TREJBALOVA, Katerina</creatorcontrib><creatorcontrib>PION, Marjorie</creatorcontrib><creatorcontrib>HIRSCH, Ivan</creatorcontrib><title>R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L− CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors</title><title>Journal of Virology</title><addtitle>J Virol</addtitle><description>Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       </description><subject>Biological and medical sciences</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD4-Positive T-Lymphocytes - virology</subject><subject>Cells, Cultured</subject><subject>Drug Resistance, Multiple, Viral</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - drug effects</subject><subject>HIV-1 - metabolism</subject><subject>HIV-1 - physiology</subject><subject>HLA-DR Antigens</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>L-Selectin - genetics</subject><subject>Leukocytes, Mononuclear</subject><subject>Lymphocyte Activation</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Palatine Tonsil</subject><subject>Pathogenesis and Immunity</subject><subject>Receptors, CCR5 - metabolism</subject><subject>Receptors, CXCR4 - metabolism</subject><subject>Reverse Transcriptase Inhibitors - pharmacology</subject><subject>Species Specificity</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Virology</subject><subject>Virus Replication - drug effects</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUUuOEzEUtBCIGQJHAHkDG9TBbn_a2SCNwmeCIhiNQsTOcpzniUfddrC7g3ID1lyDW3ESPEqUgZV_9arKVQg9p2RMaa3efFrOxoqM67ESvFJSjGtC5AN0TslEVUJQ_hCdE1LXlWDq2xl6kvMtIZRzyR-jMypZoyaqOUe_rwVemuRN6DOODl8OnQl41nVDiGtw3noIdo-XPg0ZL_ZbwBRfJXCQIPTetO0ez4ID2-PpO1nP__z8VTb8NV7gKbRtxias8UUCfBX708A1ZJ_7ooj7iD8PtoWY_RrK_Q5SBrxIJmSb_LY35TQLG7_yfUz5KXrkTJvh2XEdoa8f3i-ml9X8y8fZ9GJe2fK7vjJibRvKGtE0pp5QJx2zjFiuOGWThktwq5VkBoyyxjK34sZIpoRzNTgKjrERenvg3Q6rDta2GE-m1dvkO5P2Ohqv_38JfqNv4k5TxqVishC8OhKk-H2A3OvOZ1vyMAHikLVsxITT4nGExAFoU8y5xHoSoUTf1axLzVoRXetSsy4167uay9yLfx3eTx17LYCXR4DJ1rSuJGp9vsc1QhIlScHhA27jbzY_fAJtcqdvd_4kyv4C9kbAiA</recordid><startdate>20060101</startdate><enddate>20060101</enddate><creator>GONDOIS-REY, Francoise</creator><creator>BIANCOTTO, Angelique</creator><creator>FERNANDEZ, Marcelo Antonio</creator><creator>BETTENDROFFER, Lise</creator><creator>BLAZKOVA, Jana</creator><creator>TREJBALOVA, Katerina</creator><creator>PION, Marjorie</creator><creator>HIRSCH, Ivan</creator><general>American Society for Microbiology</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20060101</creationdate><title>R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L− CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors</title><author>GONDOIS-REY, Francoise ; BIANCOTTO, Angelique ; FERNANDEZ, Marcelo Antonio ; BETTENDROFFER, Lise ; BLAZKOVA, Jana ; TREJBALOVA, Katerina ; PION, Marjorie ; HIRSCH, Ivan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-a5dc7137577a291f6f3c30c484139746efbb63aea8cac3fb4aa6385ff2ef1ef33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Biological and medical sciences</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD4-Positive T-Lymphocytes - virology</topic><topic>Cells, Cultured</topic><topic>Drug Resistance, Multiple, Viral</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - drug effects</topic><topic>HIV-1 - metabolism</topic><topic>HIV-1 - physiology</topic><topic>HLA-DR Antigens</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>L-Selectin - genetics</topic><topic>Leukocytes, Mononuclear</topic><topic>Lymphocyte Activation</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Palatine Tonsil</topic><topic>Pathogenesis and Immunity</topic><topic>Receptors, CCR5 - metabolism</topic><topic>Receptors, CXCR4 - metabolism</topic><topic>Reverse Transcriptase Inhibitors - pharmacology</topic><topic>Species Specificity</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Virology</topic><topic>Virus Replication - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>GONDOIS-REY, Francoise</creatorcontrib><creatorcontrib>BIANCOTTO, Angelique</creatorcontrib><creatorcontrib>FERNANDEZ, Marcelo Antonio</creatorcontrib><creatorcontrib>BETTENDROFFER, Lise</creatorcontrib><creatorcontrib>BLAZKOVA, Jana</creatorcontrib><creatorcontrib>TREJBALOVA, Katerina</creatorcontrib><creatorcontrib>PION, Marjorie</creatorcontrib><creatorcontrib>HIRSCH, Ivan</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>GONDOIS-REY, Francoise</au><au>BIANCOTTO, Angelique</au><au>FERNANDEZ, Marcelo Antonio</au><au>BETTENDROFFER, Lise</au><au>BLAZKOVA, Jana</au><au>TREJBALOVA, Katerina</au><au>PION, Marjorie</au><au>HIRSCH, Ivan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L− CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors</atitle><jtitle>Journal of Virology</jtitle><addtitle>J Virol</addtitle><date>2006-01-01</date><risdate>2006</risdate><volume>80</volume><issue>2</issue><spage>854</spage><epage>865</epage><pages>854-865</pages><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue Spotlights in the Current Issue JVI About JVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions &amp; Commercial Reprints ASM Journals Public Access Policy JVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0022-538X Online ISSN: 1098-5514 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to JVI .asm.org, visit: JVI       </abstract><cop>Washington, DC</cop><pub>American Society for Microbiology</pub><pmid>16378987</pmid><doi>10.1128/JVI.80.2.854-865.2006</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of Virology, 2006-01, Vol.80 (2), p.854-865
issn 0022-538X
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1346836
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Biological and medical sciences
CD4-Positive T-Lymphocytes - immunology
CD4-Positive T-Lymphocytes - virology
Cells, Cultured
Drug Resistance, Multiple, Viral
Fundamental and applied biological sciences. Psychology
HIV Infections - virology
HIV-1 - drug effects
HIV-1 - metabolism
HIV-1 - physiology
HLA-DR Antigens
Human viral diseases
Humans
Infectious diseases
L-Selectin - genetics
Leukocytes, Mononuclear
Lymphocyte Activation
Medical sciences
Microbiology
Miscellaneous
Palatine Tonsil
Pathogenesis and Immunity
Receptors, CCR5 - metabolism
Receptors, CXCR4 - metabolism
Reverse Transcriptase Inhibitors - pharmacology
Species Specificity
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Virology
Virus Replication - drug effects
title R5 Variants of Human Immunodeficiency Virus Type 1 Preferentially Infect CD62L− CD4+ T Cells and Are Potentially Resistant to Nucleoside Reverse Transcriptase Inhibitors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T02%3A31%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=R5%20Variants%20of%20Human%20Immunodeficiency%20Virus%20Type%201%20Preferentially%20Infect%20CD62L%E2%88%92%20CD4+%20T%20Cells%20and%20Are%20Potentially%20Resistant%20to%20Nucleoside%20Reverse%20Transcriptase%20Inhibitors&rft.jtitle=Journal%20of%20Virology&rft.au=GONDOIS-REY,%20Francoise&rft.date=2006-01-01&rft.volume=80&rft.issue=2&rft.spage=854&rft.epage=865&rft.pages=854-865&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.80.2.854-865.2006&rft_dat=%3Cproquest_pubme%3E67594171%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67594171&rft_id=info:pmid/16378987&rfr_iscdi=true